| Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective SM Hays, RA Becker, HW Leung, LL Aylward, DW Pyatt Regulatory Toxicology and Pharmacology 47 (1), 96-109, 2007 | 261 | 2007 |
| Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence RA Becker, GT Ankley, SW Edwards, SW Kennedy, I Linkov, B Meek, ... Regulatory Toxicology and Pharmacology 72 (3), 514-537, 2015 | 249 | 2015 |
| Read-across approaches–misconceptions, promises and challenges ahead G Patlewicz, N Ball, RA Becker, ED Booth, MTD Cronin, D Kroese, ... ALTEX-Alternatives to animal experimentation 31 (4), 387-396, 2014 | 123 | 2014 |
| Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes G Patlewicz, TW Simon, JC Rowlands, RA Budinsky, RA Becker Regulatory Toxicology and Pharmacology 71 (3), 463-477, 2015 | 113 | 2015 |
| Alternative methods of selecting rat hepatocellular noduli resistant to 2‐acetylaminofluorene E Semple‐Roberts, MA Hayes, D Armstrong, RA Becker, WJ Racz, ... International journal of cancer 40 (5), 643-645, 1987 | 110 | 1987 |
| A survey of frameworks for best practices in weight-of-evidence analyses LR Rhomberg, JE Goodman, LA Bailey, RL Prueitt, NB Beck, C Bevan, ... Critical reviews in toxicology 43 (9), 753-784, 2013 | 104 | 2013 |
| Relationships of chemical concentrations in maternal and cord blood: a review of available data LL Aylward, SM Hays, CR Kirman, SA Marchitti, JF Kenneke, C English, ... Journal of Toxicology and Environmental Health, Part B 17 (3), 175-203, 2014 | 101 | 2014 |
| Methylation of liver DNA guanine in hydrazine hepatotoxicity: dose-response and kinetic characteristics of O 6 -methylguanine and formation and … RA Becker, LR Barrows, RC Shank Carcinogenesis 2 (11), 1181-1188, 1981 | 92 | 1981 |
| Toward the development and application of an environmental risk assessment framework for microplastic T Gouin, RA Becker, AG Collot, JW Davis, B Howard, K Inawaka, M Lampi, ... Environmental toxicology and chemistry 38 (10), 2087-2100, 2019 | 87 | 2019 |
| Guidance on assessing the methodological and reporting quality of toxicologically relevant studies: A scoping review GO Samuel, S Hoffmann, RA Wright, MM Lalu, G Patlewicz, RA Becker, ... Environment international 92, 630-646, 2016 | 81 | 2016 |
| Validation of an in vivo developmental toxicity screen in the mouse JM Seidenberg, DG Anderson, RA Becker Teratogenesis, carcinogenesis, and mutagenesis 6 (5), 361-374, 1986 | 80 | 1986 |
| Building scientific confidence in the development and evaluation of read-across G Patlewicz, N Ball, PJ Boogaard, RA Becker, B Hubesch Regulatory Toxicology and Pharmacology 72 (1), 117-133, 2015 | 72 | 2015 |
| Evaluation of EPA’s Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results CJ Borgert, EM Mihaich, TF Quill, MS Marty, SL Levine, RA Becker Regulatory Toxicology and Pharmacology 59 (3), 397-411, 2011 | 72 | 2011 |
| Hypothesis-driven weight of evidence framework for evaluating data within the US EPA’s Endocrine Disruptor Screening Program CJ Borgert, EM Mihaich, LS Ortego, KS Bentley, CM Holmes, SL Levine, ... Regulatory Toxicology and Pharmacology 61 (2), 185-191, 2011 | 68 | 2011 |
| Quantitative weight of evidence to assess confidence in potential modes of action RA Becker, V Dellarco, J Seed, JM Kronenberg, B Meek, J Foreman, ... Regulatory Toxicology and Pharmacology 86, 205-220, 2017 | 65 | 2017 |
| Toxicity testing in the 21st century: a view from the chemical industry JS Bus, RA Becker Toxicological Sciences 112 (2), 297-302, 2009 | 57 | 2009 |
| Evidence-based toxicology for the 21st century: opportunities and challenges ML Stephens, M Andersen, RA Becker, K Betts, K Boekelheide, E Carney, ... ALTEX-Alternatives to animal experimentation 30 (1), 74-103, 2013 | 56 | 2013 |
| A summary of the results of 55 chemicals screened for developmental toxicity in mice JM Seidenberg, RA Becker Teratogenesis, Carcinogenesis, and Mutagenesis 7 (1), 17-28, 1987 | 53 | 1987 |
| An exposure: activity profiling method for interpreting high-throughput screening data for estrogenic activity—Proof of concept RA Becker, KP Friedman, TW Simon, MS Marty, G Patlewicz, ... Regulatory Toxicology and Pharmacology 71 (3), 398-408, 2015 | 51 | 2015 |
| The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor RA Becker, G Patlewicz, TW Simon, JC Rowlands, RA Budinsky Regulatory Toxicology and Pharmacology 73 (1), 172-190, 2015 | 49 | 2015 |
